Article Versions Notes

Rao PS, Moore CC, Mbonde AA, Nuwagira E, Orikiriza P, Nyehangane D, Al-Shaer MH, Peloquin CA, Gratz J, Pholwat S, et al. Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics. 2021; 10(6):739. https://doi.org/10.3390/antibiotics10060739

Rao, Prakruti S., Christopher C. Moore, Amir A. Mbonde, Edwin Nuwagira, Patrick Orikiriza, Dan Nyehangane, Mohammad H. Al-Shaer, Charles A. Peloquin, Jean Gratz, Suporn Pholwat, and et al. 2021. "Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness" Antibiotics 10, no. 6: 739. https://doi.org/10.3390/antibiotics10060739

Rao, P. S., Moore, C. C., Mbonde, A. A., Nuwagira, E., Orikiriza, P., Nyehangane, D., Al-Shaer, M. H., Peloquin, C. A., Gratz, J., Pholwat, S., Arinaitwe, R., Boum, Y., Mwanga-Amumpaire, J., Houpt, E. R., Kagan, L., Heysell, S. K., & Muzoora, C. (2021). Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics, 10(6), 739. https://doi.org/10.3390/antibiotics10060739